Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CVS logo CVS
Upturn stock ratingUpturn stock rating
CVS logo

CVS Health Corp (CVS)

Upturn stock ratingUpturn stock rating
$51.57
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: CVS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -42.29%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 64.83B USD
Price to earnings Ratio 12.18
1Y Target Price 64.94
Price to earnings Ratio 12.18
1Y Target Price 64.94
Volume (30-day avg) 14947699
Beta 0.54
52 Weeks Range 43.56 - 78.21
Updated Date 01/14/2025
52 Weeks Range 43.56 - 78.21
Updated Date 01/14/2025
Dividends yield (FY) 5.54%
Basic EPS (TTM) 4.23

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 1.37%
Operating Margin (TTM) 1.59%

Management Effectiveness

Return on Assets (TTM) 2.37%
Return on Equity (TTM) 6.7%

Valuation

Trailing PE 12.18
Forward PE 8.2
Enterprise Value 137857161870
Price to Sales(TTM) 0.18
Enterprise Value 137857161870
Price to Sales(TTM) 0.18
Enterprise Value to Revenue 0.37
Enterprise Value to EBITDA 9.71
Shares Outstanding 1258409984
Shares Floating 1255563644
Shares Outstanding 1258409984
Shares Floating 1255563644
Percent Insiders 0.13
Percent Institutions 82.68

AI Summary

CVS Health Corp (CVS) Overview

Company Profile:

History and Background: Founded in 1963 as a single store in Lowell, Massachusetts, CVS Health Corporation has evolved into a Fortune 5 company offering a wide range of healthcare services. Initially operating as a drugstore chain, CVS acquired Aetna in 2018, expanding its reach into the health insurance market.

Core Business Areas:

  • Pharmacy Services: CVS operates over 9,000 retail pharmacies across the US, offering prescription dispensing, immunizations, and health consultations.
  • Health Insurance: Through Aetna, CVS provides healthcare plans to individuals, employers, and government programs.
  • Retail: CVS stores offer a wide range of products, including over-the-counter medications, health and beauty products, and convenience items.
  • Specialty Pharmacy: CVS Specialty provides medications for complex and chronic conditions, including HIV/AIDS, oncology, and rheumatoid arthritis.
  • PBM Services: CVS Caremark is a pharmacy benefit manager (PBM) that negotiates drug prices and manages pharmacy benefits for clients.

Leadership Team and Corporate Structure: Karen S. Lynch serves as President and CEO, leading a team of experienced executives across various business segments. The company operates a decentralized structure with individual business units responsible for their operations.

Top Products and Market Share:

  • MinuteClinic: CVS operates over 1,100 MinuteClinics, offering convenient and affordable walk-in healthcare services.
  • CVS Health Brand: The company offers a range of private-label products, including over-the-counter medications, vitamins, and personal care items.
  • Aetna Medicare Advantage Plans: CVS offers a variety of Medicare Advantage plans, providing seniors with comprehensive healthcare coverage.

Market Share:

  • Pharmacy Services: CVS has the largest pharmacy market share in the US, with approximately 28%.
  • Health Insurance: Aetna ranks as the third-largest health insurance provider in the US, with a market share of approximately 12%.
  • PBM Services: CVS Caremark is the largest PBM in the US, managing pharmacy benefits for over 100 million members.

Total Addressable Market:

  • US Pharmacy Market: Estimated at $450 billion in 2023.
  • US Health Insurance Market: Estimated at $1.5 trillion in 2023.

Financial Performance:

  • Revenue: $324.5 billion in 2022.
  • Net Income: $7.7 billion in 2022.
  • Profit Margin: 2.4% in 2022.
  • Earnings per Share (EPS): $8.77 in 2022.

Financial Performance Comparison: CVS has experienced steady revenue growth over the past five years, with net income fluctuating due to various factors, including acquisitions and investments.

Cash Flow and Balance Sheet: CVS maintains a strong cash flow position and a healthy balance sheet, with a debt-to-equity ratio of 0.65.

Dividends and Shareholder Returns:

  • Dividend History: CVS has a history of paying dividends, with a current dividend yield of around 1.5%.
  • Shareholder Returns: CVS stock has provided shareholders with a total return of over 50% in the past five years.

Growth Trajectory:

  • Historical Growth: CVS has experienced consistent revenue growth over the past five years, driven by acquisitions and organic growth.
  • Future Growth: The company expects continued growth in its pharmacy services and health insurance segments, fueled by an aging population and increasing demand for healthcare services.

Market Dynamics:

  • Industry Trends: The healthcare industry is undergoing significant changes, including the rise of digital health and value-based care models.
  • Demand-Supply Scenario: The demand for healthcare services is expected to continue to grow, driven by an aging population and rising chronic disease rates.
  • Technological Advancements: Technology is playing an increasingly important role in healthcare, with CVS investing in areas such as telehealth and artificial intelligence.

Market Positioning: CVS is well-positioned to benefit from these trends, with its diversified business model and investments in technology and innovation.

Competitors:

  • Pharmacy Services: Walgreens Boots Alliance (WBA), Rite Aid (RAD)
  • Health Insurance: UnitedHealth Group (UNH), Anthem (ANTM)
  • PBM Services: Express Scripts (ESRX), OptumRx

Competitive Advantages:

  • Strong Brand Recognition: CVS has a strong brand reputation and customer loyalty.
  • Large Pharmacy Network: CVS has the largest pharmacy network in the US, providing convenient access to healthcare services.
  • Diversified Business Model: CVS's diversified business model provides stability and growth opportunities.

Potential Challenges and Opportunities:

Challenges:

  • Competition: CVS faces intense competition from other pharmacy retailers and health insurance providers.
  • Regulatory Changes: The healthcare industry is subject to constant regulatory changes, which can impact CVS's operations.
  • Rising Healthcare Costs: The rising cost of healthcare is a concern for CVS and its customers.

Opportunities:

  • Growing Demand for Healthcare Services: The aging population and rising chronic disease rates are creating a growing demand for healthcare services.
  • Expansion into New Markets: CVS is exploring opportunities to expand into new markets, such as urgent care and home healthcare.
  • Digital Health: CVS is investing in digital health solutions to improve patient care and access to healthcare services.

Recent Acquisitions:

  • Signify Health (2023): This acquisition expands CVS's presence in the home health market, providing additional services to patients.
  • Oak Street Health (2022): This acquisition strengthens CVS's primary care offerings, providing patients with more convenient access to healthcare services.
  • Aetna (2018): This transformative acquisition expanded CVS's reach into the health insurance market.

AI-Based Fundamental Rating:

Rating: 8/10

Justification: CVS Health Corp. possesses a strong financial foundation, a dominant market position, and promising growth prospects. The company's diversification, investments in technology, and focus on value-based care position it well for future success. However, competitive pressures and rising healthcare costs remain potential challenges.

Sources:

  • CVS Health Corp. Annual Report 2022
  • CVS Health Corp. Investor Relations website
  • Statista
  • SEC filings

Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.

About NVIDIA Corporation

Exchange NYSE
Headquaters Woonsocket, RI, United States
IPO Launch date 1984-12-17
President, CEO & Director Mr. J. David Joyner CEBS
Sector Healthcare
Industry Healthcare Plans
Full time employees 219000
Full time employees 219000

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​